Filing Details

Accession Number:
0001651308-21-000197
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-28 17:48:31
Reporting Period:
2021-09-24
Accepted Time:
2021-09-28 17:48:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1509745 Leap Therapeutics Inc. LPTX Pharmaceutical Preparations (2834) 274412575
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1651308 Beigene, Ltd. C/O Mourant Governance Services (Cayman)
94 Solaris Avenue, Camana Bay
Grand Cayman KY1-1108
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-24 2,543,800 $2.85 7,348,437 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. On September 24, 2021, BeiGene, Ltd. purchased 2,543,800 shares of common stock of the Issuer for $2.85 per share pursuant to an underwritten public offering.